Skip to content

A randomized placebo controlled trial on effect of modified traditional Chinese medicine formula Wuzi Yanzong Pill on improving semen qualities in men with sub-optimal parameters

A randomized placebo controlled trial on effect of modified traditional Chinese medicine formula Wuzi Yanzong Pill on improving semen qualities in men with sub-optimal parameters

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010790
Enrollment
Unknown
Registered
2017-02-27
Start date
2017-03-03
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sub-optimal semen parameters

Interventions

Two groups:traditional Chinese medication modified Wuzi Yanzong Pill, Granules of herbal medicine in sachet form. taken by oral two doses per day, 3 months versus placebo

Sponsors

Prince of wales hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with one or more sub-optimal semen paremeters (Not satisfying WHO reference values in motility, morphology, concentration and total sperm count (any one of them).

Exclusion criteria

Exclusion criteria: 1. male infertility due to one testicle had been removed, history of undescended testis, previous chemotherapy, testicular torsion; 2. Patients with azoospermia; 3. Patients with normal WHO (Version 5) in all parameters.

Design outcomes

Primary

MeasureTime frame
Does WYP improve semen quality in patient with abnormal semen parameters? Are overall parameters improved?;

Secondary

MeasureTime frame
Does modified WYP alter FSH and free androgen index in men with suboptimal semen parameters?;

Countries

China

Contacts

Public ContactProfessor Li Tin Chiu

Department of Obstetric and Gynaecology, Prince of wales hospital

tinchiu.li@cuhk.edu.hk+852 2632 2800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026